Validation of an Alzheimer’s disease assessment battery in Asian participants with mild to moderate Alzheimer’s disease

Joan H.Q. Shen*, Qi Shen, Holly Yu, Jin Shei Lai, Jennifer L. Beaumont, Zhenxin Zhang, Huali Wang, Seong Yoon Kim, Christopher Chen, Timothy Kwok, Shuu Jiun Wang, Dong Young Lee, John Harrison, Jeffrey Cummings

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

There is a lack of validated tools for assessing Alzheimer’s disease (AD) across Asia. This study evaluates the psychometric properties of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), Disability Assessment for Dementia (DAD), and Neuropsychological Test Battery (NTB) in Asian participants. Participants with mild to moderate AD (n=251) and healthy controls (n=51) from Mainland China, Taiwan, Singapore, Hong Kong, and South Korea completed selected instruments at several time points. Test-retest reliability was better than 0.70 for all tests. AD participants performed significantly more poorly than controls on every score. Within the AD group, greater disease severity corresponded to significantly poorer performance. The AD group test performance worsened over time and there was a trend for worse performance in AD compared to healthy controls over time. The ADAS-Cog, DAD, and NTB are reliable, valid, and responsive measures in this population and could be used for clinical trials across Asian countries/regions.

Original languageEnglish (US)
Pages (from-to)158-169
Number of pages12
JournalAmerican Journal of Neurodegenerative Diseases
Volume3
Issue number3
StatePublished - Jan 1 2014

Keywords

  • Alzheimer’s disease
  • Validation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Validation of an Alzheimer’s disease assessment battery in Asian participants with mild to moderate Alzheimer’s disease'. Together they form a unique fingerprint.

Cite this